Sun Pharma Advanced Research Company Limited
Sun Pharma Advanced Research Company Limited (SPARC): company summary
The company's business has improved significantly, with annual net profit swinging from a loss of ₹345 crore to a profit of ₹1,553 crore.
Sun Pharma Advanced Research Company Limited (SPARC) is a small-cap Healthcare company valued at ₹6,122 crore operating in Pharmaceuticals on the NSE and BSE.
- Recent price move
- Sun Pharma Advanced Research Company Limited last traded at ₹187.81, modestly down 0.27% on the day.
- Recent developments
- On 2026-10-04, Sun Pharma Advanced Research won a ₹28 crore CENVAT credit refund case in CESTAT, which may improve its cash flow and reduce tax liabilities.
- Financial performance
- The company's business has improved significantly, with annual net profit swinging from a loss of ₹345 crore to a profit of ₹1,553 crore. However, the latest quarter showed a net loss of ₹21 crore, narrowing from a loss of ₹52 crore in the same quarter a year earlier.
- Valuation multiples
- The stock trades at 3.9 times earnings, a discount to the Healthcare median of 32.0, 4.71 times book value.
- Things to watch
- The latest quarter reported a net loss of ₹21 crore, which is a concern. The stock is 34.7% below its 52-week high, indicating a significant drop from recent peak levels.
- Where it stands
- The company has seen a dramatic improvement in annual net profit, but the latest quarter's loss highlights ongoing challenges. The stock's distance below its 52-week high is the most significant figure to note.
Summarised by DocStoX's model on 2026-10-17 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by valuation (9.0) and quality (6.5), but weakest on growth (4.1).
DocStoX score
Low confidenceAt a glance
Key highlights
- Strong returns on equity (116%)
- Capital works hard — ROCE 84%
- Healthy net margin (83%)
- Profit shrinking 0% a year
- Loss-making in some of the last 5 years
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Sun Pharma Advanced Research Company Limited’s valuation
Free deep-dive tools · no sign-up
Sun Pharma Advanced Research Company Limited peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Compare Sun Pharma Advanced Research Company Limited with peers
Related tools & concepts
Value Sun Pharma Advanced Research Company Limited with the ratios and calculators DocStoX uses in its analysis.

